Insights on the Potential for Gene Therapy for Hemophilia: An Inside Look at the Clinical Trial Experience

Insights on the Potential for Gene Therapy for Hemophilia: An Inside Look at the Clinical Trial Experience

Insights on the Potential for Gene Therapy for Hemophilia: An Inside Look at the Clinical Trial Experience
RestartResume

When factor replacement therapy isn't the best option for your patient, could gene therapy be the solution?

  • Overview

    Factor replacement therapy is commonly used to treat hemophilia B, but could gene therapy be a useful alternative? Dr. Jennifer Caudle joins Dr. Robert Klamroth from the Vivantes Friedrichshain Hospital in Berlin, Germany, and Dr. Richard S. Lemons from the University of Utah Huntsman Cancer Institute to share their clinical trial experience with gene therapy in patients with hemophilia B. 

  • Disclaimer

    Gene therapy for hemophilia B is currently under clinical investigation and is not approved by any regulatory authority for therapeutic use. 

    This non-certified educational episode is sponsored by CSL Behring. Content for this episode is produced and controlled by ReachMD. This episode is intended for healthcare professionals only. 

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free